Thus, our data do not confirm the findings of Berstein et al. [15] who, in 90 postmenopausal BC patients with DM, observed a higher rate of positive progesterone receptors in patients on metformin when compared to those on sulphonylurea or insulin (73% vs. 37%). The gene discussed is INS; the disease is breast cancer.